← FDA Drug Approvals (Drugs@FDA)

MOMETASONE FUROATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARMA CANADA · Approved 2004-12-21

Drug application

FDA Application #
ANDA076679
Application type
Abbreviated New Drug Application (Generic)
Brand name
MOMETASONE FUROATE
Generic name
MOMETASONE FUROATE
Active ingredients
MOMETASONE FUROATE
Dosage form
CREAM
Route
TOPICAL
Marketing status
Prescription
Sponsor
SUN PHARMA CANADA
Manufacturer
Padagis Israel Pharmaceuticals Ltd
First approval
2004-12-21

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown